Digestive & Bowel Disorders
Digestive & Bowel Disorders
Digestive and bowel disorders include colitis, Crohn’s disease, inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS) and may cause pain, nausea, vomiting, bloating, constipation, diarrhea, or fatigue.
Ohio researchers found Crohn’s Disease symptoms were lower in patients using cannabis
Quick Hit
Project CBD interviews Kelly Dunn and Josh Sarvis about sustainable and regenerative growing practices.
Video
Three authors highlight that cannabis has shows better results than CBD alone for IBD
Quick Hit
Project CBD discusses the benefits of CBD, the "entourage effect" and the microbiome with Dr. Ethan Russo.
Video
Discover the clinical and laboratory research on THCA for epilepsy, chronic pain, digestive disorders, and more.
Article
Science abstracts on CBD and Digestive & Bowel Disorders
- CBD in inflammatory bowel diseases: a brief overview
- Cannabis finds its way into treatment of Crohn’s disease
- CBD reduces intestinal inflammation through the control of neuroimmune axis
- Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
- The effects of Delta-tetrahydrocannabinol and CBD alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
- Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice
- Cannabinoids and the gut: New developments and emerging concepts
- Endocannabinoids and the gastrointestinal tract
- Cannabinoids and gastrointestinal motility: Animal and human studies
- Hergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis
- Manipulation of the endocannabinoid system in colitis: A comprehensive review
- Low-dose cannabidiol is safe but not effective in the treatment for Crohn's Disease, a randomized controlled trial
- Cannabidiol in inflammatory bowel diseases: A brief overview
- CBD reduces intestinal inflammation through the control of neuroimmune axis
- Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
- Cannabinoid actions at TRPV channels: Effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
- Endocannabinoids and the gastrointestinal tract
- CBD and gastrointestinal motility
- Getting into the weed: the role of the endocannabinoid system in the brain-gut axis
- Cannabinoids and GI disorders: Endogenous and exogenous
These links are from third-party sites and are provided as a courtesy to the reader.
Top Stories
THE ESSENTIAL GUIDE TO CBD
By the Editors of Reader’s Digest & Project CBD: Everything You Need to Know About What It Helps, Where to Buy It, and How to Take It.